Skip to main content
AZTA
NASDAQ Life Sciences

Azenta Q3 EPS Beats by 45%, Revenue Jumps 12%; Guides FY26 Revenue Above $613M

Tom Rudovsky · Reported by Reuters
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$30
Mkt Cap
$1.389B
52W Low
$15.93
52W High
$41.73
52W Position info
88% above low
Off High info
28% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

AZTA sits 88% above its 52-week low of $15.93.

Summary

Azenta delivered a strong Q3, with adjusted EPS of $0.16 beating consensus by 45% and revenue up 12% year-over-year. Growth was driven by Sample Management Solutions and Multiomics, though gross margin dipped due to fixed-cost absorption and quality remediation in Automated Stores. The company also repurchased $50M in shares under its existing buyback program. FY26 guidance calls for revenue of $613M-$618M and adjusted EBITDA of $59M-$62M, providing a clear outlook after the Q2 goodwill impairment and B Medical Systems sale. This follows the Q2 net loss of $160.8M and the $63M B Medical divestiture, marking a turnaround quarter. The stock trades at 52x forward earnings, reflecting high expectations that this beat may reinforce.

Updates

  1. · SEC 10-Q — The 10-Q reports Q3 net income of $2.5M, nine-month net loss of $173.8M, and completion of the B Medical Systems sale on July 1, 2026 for $63.0M.

At the time of this announcement, AZTA was trading at $30.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.4B. The 52-week trading range was $15.93 to $41.73. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

AZTA - Latest Insights

AZTA
Nov 19, 2026, 4:06 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $47.09
Real-time Price: $44.80 info
Change: -$2.29 (-5%) info
Market Cap: $1.879B info
AZTA
Nov 10, 2026, 5:44 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $44.20
Real-time Price: $44.80 info
Change: +$0.600 (+1%) info
Market Cap: $1.879B info
AZTA
Nov 10, 2026, 4:30 PM EST
Source: PR Newswire
Importance Score:
8
Price at Filing: $39.99
Real-time Price: $44.80 info
Change: +$4.81 (+12%) info
Market Cap: $1.879B info
AZTA
Oct 30, 2026, 8:02 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $39.87
Real-time Price: $44.80 info
Change: +$4.93 (+12%) info
Market Cap: $1.879B info
AZTA
Oct 07, 2026, 8:01 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $40.04
Real-time Price: $44.80 info
Change: +$4.76 (+12%) info
Market Cap: $1.879B info